Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites

Paola Sabbatini; Petrine Wellendorph; Signe Høg; Martin Holst Friborg Pedersen; Hans Bräuner-Osborne; Lars Martiny; Bente Flensborg Frølund; Rasmus Prætorius Clausen

doi:10.1021/jm1006325

Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites

Paola Sabbatini, Petrine Wellendorph, Signe Høg, Martin Holst Friborg Pedersen, Hans Bräuner-Osborne, Lars Martiny, Bente Flensborg Frølund, Rasmus Prætorius Clausen

17 Citations (Scopus)

Abstract

γ-Hydroxybutyric acid (GHB) is a psychotropic compound endogenous to the brain. Despite its potential physiological significance, the complete molecular mechanisms of action remain unexplained. To facilitate the isolation and identification of the high-affinity GHB binding site, we herein report the design and synthesis of the first ¹²⁵I-labeled radioligands in the field, one of which contains a photoaffinity label which enables it to bind irreversibly to the high-affinity GHB binding sites.

Original language	English
Journal	Journal of Medicinal Chemistry
Volume	53
Issue number	17
Pages (from-to)	6506-6510
ISSN	0022-2623
DOIs	https://doi.org/10.1021/jm1006325
Publication status	Published - 9 Sept 2010

Keywords

Former Faculty of Pharmaceutical Sciences

Access to Document

10.1021/jm1006325

Fingerprint

Dive into the research topics of 'Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites'. Together they form a unique fingerprint.

Cite this

Sabbatini, P., Wellendorph, P., Høg, S., Pedersen, M. H. F., Bräuner-Osborne, H., Martiny, L., Frølund, B. F., & Clausen, R. P. (2010). Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites. Journal of Medicinal Chemistry, 53(17), 6506-6510. https://doi.org/10.1021/jm1006325

Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites. / Sabbatini, Paola; Wellendorph, Petrine; Høg, Signe et al.
In: Journal of Medicinal Chemistry, Vol. 53, No. 17, 09.09.2010, p. 6506-6510.

Research output: Contribution to journal › Journal article › Research › peer-review

Sabbatini, P, Wellendorph, P, Høg, S, Pedersen, MHF, Bräuner-Osborne, H, Martiny, L, Frølund, BF & Clausen, RP 2010, 'Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites', Journal of Medicinal Chemistry, vol. 53, no. 17, pp. 6506-6510. https://doi.org/10.1021/jm1006325

Sabbatini P, Wellendorph P, Høg S, Pedersen MHF, Bräuner-Osborne H, Martiny L et al. Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites. Journal of Medicinal Chemistry. 2010 Sept 9;53(17):6506-6510. doi: 10.1021/jm1006325

@article{66fd0990b75011df825b000ea68e967b,

title = "Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites",

abstract = "γ-Hydroxybutyric acid (GHB) is a psychotropic compound endogenous to the brain. Despite its potential physiological significance, the complete molecular mechanisms of action remain unexplained. To facilitate the isolation and identification of the high-affinity GHB binding site, we herein report the design and synthesis of the first 125I-labeled radioligands in the field, one of which contains a photoaffinity label which enables it to bind irreversibly to the high-affinity GHB binding sites.",

keywords = "Former Faculty of Pharmaceutical Sciences",

author = "Paola Sabbatini and Petrine Wellendorph and Signe H{\o}g and Pedersen, {Martin Holst Friborg} and Hans Br{\"a}uner-Osborne and Lars Martiny and Fr{\o}lund, {Bente Flensborg} and Clausen, {Rasmus Pr{\ae}torius}",

year = "2010",

month = sep,

day = "9",

doi = "10.1021/jm1006325",

language = "English",

volume = "53",

pages = "6506--6510",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "17",

}

TY - JOUR

T1 - Design, synthesis, and in vitro pharmacology of new radiolabeled ¿-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity ¿-hydroxybutyric acid binding sites

AU - Sabbatini, Paola

AU - Wellendorph, Petrine

AU - Høg, Signe

AU - Pedersen, Martin Holst Friborg

AU - Bräuner-Osborne, Hans

AU - Martiny, Lars

AU - Frølund, Bente Flensborg

AU - Clausen, Rasmus Prætorius

PY - 2010/9/9

Y1 - 2010/9/9

N2 - γ-Hydroxybutyric acid (GHB) is a psychotropic compound endogenous to the brain. Despite its potential physiological significance, the complete molecular mechanisms of action remain unexplained. To facilitate the isolation and identification of the high-affinity GHB binding site, we herein report the design and synthesis of the first 125I-labeled radioligands in the field, one of which contains a photoaffinity label which enables it to bind irreversibly to the high-affinity GHB binding sites.

AB - γ-Hydroxybutyric acid (GHB) is a psychotropic compound endogenous to the brain. Despite its potential physiological significance, the complete molecular mechanisms of action remain unexplained. To facilitate the isolation and identification of the high-affinity GHB binding site, we herein report the design and synthesis of the first 125I-labeled radioligands in the field, one of which contains a photoaffinity label which enables it to bind irreversibly to the high-affinity GHB binding sites.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1021/jm1006325

DO - 10.1021/jm1006325

M3 - Journal article

C2 - 20715819

SN - 0022-2623

VL - 53

SP - 6506

EP - 6510

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 17

ER -